Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bosso

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The Annals of Pharmacotherapy|June 1, 1996
The role of dornase alfa in the treatment of cystic fibrosisG W Cramer, J A Bosso
Diabetes|October 1, 1973
Sugar content of selected liquid medicinalsJ A Bosso, R E Pearson
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Efficacy of ciprofloxacin in patients with cystic fibrosisJ A Bosso, P G Black
Pharmacotherapy|January 1, 1991
The use of aztreonam in pediatric patients: a reviewJ A Bosso, P G Black
The Annals of Pharmacotherapy|January 7, 1998
Added qualifications for pharmacy specialists: another perspectiveJ A Bosso, T C Hardin
Drugs|May 1, 1992
Treatment options for the pharmacological therapy of neonatal meningitisC M Paap, J A Bosso
American Journal of Hospital Pharmacy|October 1, 1985
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutionsJ A Bosso, R J Townsend
The Pediatric Infectious Disease Journal|September 1, 1989
The use of aztreonam in the cystic fibrosis patientJ M Matsen, J A Bosso
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Clinical pharmacy and clinical researchJ M Nappi, J A Bosso
Journal of Clinical Pharmacology|March 1, 1985
Tolerance and percutaneous absorption of topically applied arildoneJ A Bosso, S L Spruance, G Wenerstrom
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The Annals of Pharmacotherapy|June 1, 1996
The role of dornase alfa in the treatment of cystic fibrosisG W Cramer, J A Bosso
Diabetes|October 1, 1973
Sugar content of selected liquid medicinalsJ A Bosso, R E Pearson
Drug Intelligence & Clinical Pharmacy|July 1, 1988
Efficacy of ciprofloxacin in patients with cystic fibrosisJ A Bosso, P G Black
Pharmacotherapy|January 1, 1991
The use of aztreonam in pediatric patients: a reviewJ A Bosso, P G Black
The Annals of Pharmacotherapy|January 7, 1998
Added qualifications for pharmacy specialists: another perspectiveJ A Bosso, T C Hardin
Drugs|May 1, 1992
Treatment options for the pharmacological therapy of neonatal meningitisC M Paap, J A Bosso
American Journal of Hospital Pharmacy|October 1, 1985
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutionsJ A Bosso, R J Townsend
The Pediatric Infectious Disease Journal|September 1, 1989
The use of aztreonam in the cystic fibrosis patientJ M Matsen, J A Bosso
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Clinical pharmacy and clinical researchJ M Nappi, J A Bosso
Journal of Clinical Pharmacology|March 1, 1985
Tolerance and percutaneous absorption of topically applied arildoneJ A Bosso, S L Spruance, G Wenerstrom
Pageof 8